MEREO BIOPHARMA GROUP PL-ADR (MREO) Stock Earnings & Estimates
USA - NASDAQ:MREO - US5894921072 - ADR
1.73 USD
-0.03 (-1.7%)
1.74 USD
+0.01 (+0.58%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 50.14M | -100.00% | 10M | -100.00% | 28.426M | 48.937M 72.16% | 96.555M 97.30% | 160.02M 65.73% | 249.84M 56.13% | 363.83M 45.63% | 508.82M 39.85% | 644.39M 26.64% | |
| EBITDA YoY % growth | -27.905M 39.49% | -52.781M -89.15% | -27.355M 48.17% | -53.026M -69.17% | -19.863M 57.08% | 743.876K 103.75% | 22.803M 2,965.43% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -28.788M 40.24% | -53.677M -86.46% | -28.416M 47.06% | -43.817M -66.68% | -39.263M 17.10% | -20.051M 48.93% | 5.405M 126.96% | 42.927M 694.21% | 114.1M 165.80% | 206.75M 81.20% | 332.94M 61.04% | 449.82M 35.11% | |
| Operating Margin | -57.42% | N/A | -284.16% | N/A | -138.12% | -40.97% | 5.60% | 26.83% | 45.67% | 56.83% | 65.43% | 69.81% | |
| EPS YoY % growth | N/A 88.68% | N/A -47.54% | N/A 38.67% | -0.06 -8.58% | -0.06 -9.51% | -0.05 18.41% | -0.01 80.65% | 0.04 498.00% | 0.11 164.57% | 0.19 80.06% | 0.33 68.67% | 0.44 35.87% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 75.22% | 0.02 140.81% | -0.02 84.70% | -0.02 84.70% | -0.02 27.95% | -0.01 -137.50% |
| Revenue Q2Q % growth | 11.9M | 22.015M | 9.563M 1,812.60% | -100.00% | 27.343M 24.20% | |
| EBITDA Q2Q % growth | -11.22M -31.09% | 39.78M 380.40% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.68M 50.07% | -3.938M 74.22% | -13.227M -20.24% | -4.407M 58.02% | -15.639M -234.15% | 3.741M 195.00% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.10 | -0.02 | -0.08 | -499.63% |
| Q1 2025 Q2Q % growth | -0.10 | -0.01 | -0.09 | -1,246.69% |
| Q4 2024 Q2Q % growth | -0.05 -19,503.92% | -0.01 | -0.04 | -240.11% |
| Q3 2024 Q2Q % growth | -0.10 | -0.02 | -0.08 | -459.58% |
| Q2 2024 Q2Q % growth | -0.10 -48,919.61% | -0.01 | -0.09 | -877.46% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 19.063M | -19.063M | -100.00% | |
| Q4 2024 Q2Q % growth | -100.00% | % | ||
| Q2 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | 10M | 37.23M | -27.23M | -73.14% |
| Q2 2022 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -15.89% | 85.12% | -18.39% | -25.76% |
| Revenue | 0% | N/A | -15.4% | 20.11% |